Dicycloverine


Thông tin thuốc gốc
Chỉ định và Liều dùng
Intramuscular
Irritable bowel syndrome
Adult: 10-20 mg 4 times daily for 1-2 days if oral therapy is temporarily impractical.

Oral
Gastrointestinal tract spasm
Adult: 10-20 mg tid. Dose is individualised according to patient needs. Dosing recommendations may vary among individual products and between countries (refer to specific product guidelines).
Child: 6 months to <2 years 5-10 mg 3-4 times daily. 2-12 years 10 mg tid. >12 years Same as adult dose. Dosing recommendations may vary among individual products and between countries (refer to specific product guidelines).
Cách dùng
May be taken with or without food.
Chống chỉ định
Obstructive disease of the gastrointestinal tract, reflux oesophagitis, severe ulcerative colitis, unstable CV status in acute haemorrhage, glaucoma, obstructive uropathy, myasthenia gravis, salmonella dysentery. Infants <6 months. Lactation.
Thận trọng
Patient with coronary artery disease, heart failure, hypertension, tachyarrhythmia (e.g. thyrotoxicosis), hyperthyroidism, autonomic neuropathy, known or suspected prostatic hyperplasia, mild to moderate ulcerative colitis, altered physical or mental abilities, fever. Patients undergoing cardiac surgery. Presence of increased environmental temperature (e.g. hot weather, exercise). Renal and hepatic impairment. Children and elderly. Pregnancy.
Tác dụng không mong muốn
Significant: Drowsiness, blurred vision, diarrhoea, heat prostration (in increased environmental temperature), psychosis and delirium (especially elderly and mentally ill patients).
Cardiac disorders: Palpitations, tachyarrhythmia.
Eye disorders: Mydriasis, cycloplegia, photophobia.
Gastrointestinal disorders: Dry mouth, thirst, constipation, nausea, vomiting, abdominal pain, abdominal distension, dyspepsia.
General disorders and admin site conditions: Fatigue, asthenia.
Metabolism and nutrition disorders: Anorexia.
Nervous system disorders: Dizziness, sedation, headache, nervousness.
Psychiatric disorders: Insomnia.
Renal and urinary disorders: Dysuria.
Reproductive system and breast disorders: Suppressed lactation.
Respiratory, thoracic and mediastinal disorders: Dyspnoea, nasal congestion, reduced bronchial secretions.
Skin and subcutaneous tissue disorders: Rash, allergic dermatitis, erythema.
Vascular disorders: Flushing.
Thông tin tư vấn bệnh nhân
This drug may cause drowsiness or blurred vision, if affected, do not drive or operate machinery.
Chỉ số theo dõi
Monitor urinary output, anticholinergic effects, and gastrointestinal symptoms.
Quá liều
Symptoms: Headache, dizziness, nausea, vomiting, dry mouth, difficulty swallowing, dilated pupils, blurred vision; hot, dry skin; CNS stimulation, convulsion. Management: Symptomatic treatment. May perform gastric lavage or administer emetics and activated charcoal. May administer sedatives (e.g. benzodiazepines, short-acting barbiturates) to manage overt signs of excitement. May use appropriate parenteral cholinergic agent as antidote.
Tương tác
Enhanced adverse effect with other anticholinergic agents (e.g. amantadine, quinidine, antihistamines, phenothiazine, benzodiazepines, MAOIs, meperidine, nitrates and nitrites, TCAs, sympathomimetic agents). May antagonize the effects of antiglaucoma agents. May diminish the therapeutic effect of gastrokinetic drugs (e.g. metoclopramide). Altered absorption with antacids.
Tác dụng
Description: Dicycloverine, a tertiary amine antimuscarinic, relieves gastrointestinal smooth muscle spasm by blocking the action of acetylcholine at parasympathetic sites in the smooth muscle, CNS and secretory glands.
Synonym: dicyclomine.
Onset: 1-2 hours.
Duration: Up to 4 hours.
Pharmacokinetics:
Absorption: Rapid and well absorbed. Bioavailability: IM: Approx 2 times more bioavailable than oral administration. Time to peak plasma concentration: 60-90 minutes (oral).
Distribution: Enters breast milk. Volume of distribution: 3.65 L/kg.
Metabolism: Extensively metabolised.
Excretion: Mainly via urine (80%, small amounts as unchanged drug); faeces (8%). Elimination half-life: Approx 1.8 hours (initial phase).
Đặc tính

Chemical Structure Image

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 3042, Dicyclomine. https://pubchem.ncbi.nlm.nih.gov/compound/Dicyclomine. Accessed May 26, 2022.

Bảo quản
Store between 20-30°C. Cap/tab/oral solution: Protect from direct sunlight and excessive heat. Inj: Protect from freezing. Storage recommendations may vary among individual products (refer to specific product guidelines).
Phân loại MIMS
Thuốc chống co thắt
Phân loại ATC
A03AA07 - dicycloverine ; Belongs to the class of synthetic anticholinergics, esters with tertiary amino group. Used in the treatment of functional bowel disorders.
Tài liệu tham khảo
Anon. Dicyclomine. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 16/05/2022.

Anon. Dicycloverine (Dicyclomine). Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 01/03/2022.

Buckingham R (ed). Dicycloverine Hydrochloride. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 01/03/2022.

Dicyclomine Hydrochloride Injection (Akorn). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 01/03/2022.

Dicyclomine Hydrochloride Solution (Remedyrepack Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 01/03/2022.

Dicyclomine Hydrochloride Tablet (RedPharm Drug, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 01/03/2022.

Dicycloverine Hydrochloride 10 mg/5 mL Oral Solution (Zentiva Pharma UK Limited). MHRA. https://products.mhra.gov.uk. Accessed 01/03/2022.

Dicycloverine Hydrochloride Capsule (Bryant Ranch Prepack). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 01/03/2022.

Dicycloverine Hydrocholoride 20 mg Tablets (Zentiva Pharma UK Limited). MHRA. https://products.mhra.gov.uk. Accessed 01/03/2022.

Dicymed 10 mg/5 mL Syrup, 10 mg Tablet (Lloyd Laboratories, Inc.). MIMS Philippines. http://www.mims.com/philippines. Accessed 01/03/2022.

Joint Formulary Committee. Dicycloverine Hydrochloride. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 01/03/2022.

Ritemed Dicycloverine Hydrochloride (Ritemed Phils., Inc.). MIMS Philippines. http://www.mims.com/philippines. Accessed 01/03/2022.

Spasdon 5 mg/mL Syrup (Oral Drops) (AD-Drugstel Pharmaceutical Laboratories, Inc.). MIMS Philippines. http://www.mims.com/philippines. Accessed 01/03/2022.

Spasmin Tablet (Prime Pharmaceutical Sdn. Bhd.). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. https://www.npra.gov.my. Accessed 01/03/2022.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Dicycloverine từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2022 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in